Parallel TLR5 signaling through the MyD88/TRAF6 complex elevates IL-6 production and induces galectin-1 secretion via myeloid-derived suppressor cells (MDSCs) and γδ T cells, collectively fostering tumor progression [18]. Here, IL6 is linked to neoplasm.